- Home
- STRO vs LSBK Comparison
STRO vs LSBK Comparison
Compare STRO & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- LSBK
- Stock Information
- Founded
- STRO 2003
- LSBK 1891
- Country
- STRO United States
- LSBK United States
- Employees
- STRO N/A
- LSBK N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- LSBK Savings Institutions
- Sector
- STRO Health Care
- LSBK Finance
- Exchange
- STRO Nasdaq
- LSBK Nasdaq
- Market Cap
- STRO 76.5M
- LSBK 90.0M
- IPO Year
- STRO 2018
- LSBK 2006
- Fundamental
- Price
- STRO $0.91
- LSBK $12.96
- Analyst Decision
- STRO Hold
- LSBK
- Analyst Count
- STRO 7
- LSBK 0
- Target Price
- STRO $1.97
- LSBK N/A
- AVG Volume (30 Days)
- STRO 480.6K
- LSBK 22.4K
- Earning Date
- STRO 11-12-2025
- LSBK 10-22-2025
- Dividend Yield
- STRO N/A
- LSBK 2.78%
- EPS Growth
- STRO N/A
- LSBK 39.59
- EPS
- STRO N/A
- LSBK 1.05
- Revenue
- STRO $104,473,000.00
- LSBK $26,488,000.00
- Revenue This Year
- STRO $65.48
- LSBK N/A
- Revenue Next Year
- STRO N/A
- LSBK N/A
- P/E Ratio
- STRO N/A
- LSBK $12.38
- Revenue Growth
- STRO N/A
- LSBK 1.75
- 52 Week Low
- STRO $0.52
- LSBK $11.50
- 52 Week High
- STRO $4.60
- LSBK $13.48
- Technical
- Relative Strength Index (RSI)
- STRO 52.61
- LSBK 48.20
- Support Level
- STRO $0.84
- LSBK $12.88
- Resistance Level
- STRO $0.95
- LSBK $13.22
- Average True Range (ATR)
- STRO 0.06
- LSBK 0.16
- MACD
- STRO -0.00
- LSBK -0.04
- Stochastic Oscillator
- STRO 65.42
- LSBK 16.00
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.